source
- Merck pulls Recarbrio antibiotic from U.S. market, raising concerns over superbug resistanceMerck announced it has stopped supplying Recarbrio in the United States earlier this month. Recarbrio, a three‑drug combination injection approved seven years ago, is used for severe infections su…
- AbbVie receives FDA approval for Parkinson’s drug Juvmo, a Cerevel acquisition assetAbbVie has secured FDA approval for tavapadon, marketed as Juvmo, for the treatment of Parkinson’s disease in adults. The decision follows positive results from the Phase 3 TEMPO trial. In the piv…